Literature DB >> 33113495

Phage engineering and the evolutionary arms race.

Huan Peng1, Irene A Chen2.   

Abstract

Phages are versatile agents for delivering a variety of cargo, including nanomaterials, nucleic acids, and small molecules. A potentially important application is treatment of antibiotic-resistant infections. All of these applications require molecular engineering of the phages, including chemical modification and genetic engineering. Phages are remarkably amenable to such engineering. We review some examples, including for controlled phage therapy. We suggest that the ability of phages to support extensive engineering may have evolutionary origins in the billions-year-old 'arms race' between bacteria and phages, which selects for sequences and structures that are robust in the face of rapid evolutionary change. This leads to high tolerance of both naturally evolved mutations and synthetic molecular engineering.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33113495      PMCID: PMC8062571          DOI: 10.1016/j.copbio.2020.09.009

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  61 in total

1.  Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.

Authors:  Yang Pan; Yuan Zhang; Tingting Jia; Kuo Zhang; Jinming Li; Lunan Wang
Journal:  FEBS J       Date:  2012-02-23       Impact factor: 5.542

2.  Lysogenic conversion by a filamentous phage encoding cholera toxin.

Authors:  M K Waldor; J J Mekalanos
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

3.  Implementation of P22 viral capsids as intravascular magnetic resonance T1 contrast conjugates via site-selective attachment of Gd(III)-chelating agents.

Authors:  Junseon Min; Hoesu Jung; Hyun-Hee Shin; Gyunggoo Cho; HyungJoon Cho; Sebyung Kang
Journal:  Biomacromolecules       Date:  2013-06-24       Impact factor: 6.988

4.  MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform.

Authors:  Francis A Galaway; Peter G Stockley
Journal:  Mol Pharm       Date:  2012-11-14       Impact factor: 4.939

5.  Refactored M13 bacteriophage as a platform for tumor cell imaging and drug delivery.

Authors:  Debadyuti Ghosh; Aditya G Kohli; Felix Moser; Drew Endy; Angela M Belcher
Journal:  ACS Synth Biol       Date:  2012-09-24       Impact factor: 5.110

6.  Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.

Authors:  Carlee E Ashley; Eric C Carnes; Genevieve K Phillips; Paul N Durfee; Mekensey D Buley; Christopher A Lino; David P Padilla; Brandy Phillips; Mark B Carter; Cheryl L Willman; C Jeffrey Brinker; Jerri do Carmo Caldeira; Bryce Chackerian; Walker Wharton; David S Peabody
Journal:  ACS Nano       Date:  2011-06-07       Impact factor: 15.881

7.  Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.

Authors:  Takeaki Matsuda; Tracy A Freeman; David W Hilbert; Michael Duff; Michele Fuortes; Philip P Stapleton; John M Daly
Journal:  Surgery       Date:  2005-06       Impact factor: 3.982

8.  Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer Models.

Authors:  Ioana L Aanei; Adel M ElSohly; Michelle E Farkas; Chawita Netirojjanakul; Melanie Regan; Stephanie Taylor Murphy; James P O'Neil; Youngho Seo; Matthew B Francis
Journal:  Mol Pharm       Date:  2016-09-30       Impact factor: 4.939

9.  Phage liquid crystalline droplets form occlusive sheaths that encapsulate and protect infectious rod-shaped bacteria.

Authors:  Abul K Tarafder; Andriko von Kügelgen; Adam J Mellul; Ulrike Schulze; Dirk G A L Aarts; Tanmay A M Bharat
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

10.  In vivo gene delivery and expression by bacteriophage lambda vectors.

Authors:  H A Lankes; C N Zanghi; K Santos; C Capella; C M P Duke; S Dewhurst
Journal:  J Appl Microbiol       Date:  2007-05       Impact factor: 3.772

View more
  8 in total

Review 1.  Mechanisms of interactions between bacteria and bacteriophage mediate by quorum sensing systems.

Authors:  Yuxin Wang; Jianjun Dai; Xuhang Wang; Yang Wang; Fang Tang
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-21       Impact factor: 4.813

2.  The Effect of Zero-Valent Iron Nanoparticles (nZVI) on Bacteriophages.

Authors:  Sada Raza; Michał Folga; Marcin Łoś; Zenon Foltynowicz; Jan Paczesny
Journal:  Viruses       Date:  2022-04-22       Impact factor: 5.818

Review 3.  Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens.

Authors:  Jennifer Venhorst; Jos M B M van der Vossen; Valeria Agamennone
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

4.  Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.

Authors:  Małgorzata Łobocka; Krystyna Dąbrowska; Andrzej Górski
Journal:  BioDrugs       Date:  2021-04-21       Impact factor: 5.807

Review 5.  Bacteriophages as Solid Tumor Theragnostic Agents.

Authors:  Srivani Veeranarayanan; Aa Haeruman Azam; Kotaro Kiga; Shinya Watanabe; Longzhu Cui
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

6.  Treatment of Wound Infections in a Mouse Model Using Zn2+-Releasing Phage Bound to Gold Nanorods.

Authors:  Huan Peng; Daniele Rossetto; Sheref S Mansy; Maria C Jordan; Kenneth P Roos; Irene A Chen
Journal:  ACS Nano       Date:  2022-03-03       Impact factor: 15.881

Review 7.  In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success.

Authors:  Tea Glonti; Jean-Paul Pirnay
Journal:  Viruses       Date:  2022-07-07       Impact factor: 5.818

8.  Hijacking the self-replicating machine of bacteriophage for PCR-based cascade signal amplification in detecting SARS-CoV-2 viral marker protein in serum.

Authors:  Jialei Du; Daili Xiang; Fushan Liu; Leichen Wang; Hao Li; Liu Gong; Xiangyu Fan
Journal:  Sens Actuators B Chem       Date:  2022-10-14       Impact factor: 9.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.